Radiology Reads in Seconds. Accuracy That Matters.
Diagnosify brings clinical-grade AI to diagnostic imaging — enabling faster, more consistent reads across radiology, emergency medicine, and teleradiology.
Diagnosify brings clinical-grade AI to diagnostic imaging — enabling faster, more consistent reads across radiology, emergency medicine, and teleradiology.
Four modalities. One integrated platform. Peer-reviewed performance benchmarks.
Automated detection of pneumonia, pleural effusion, pneumothorax, and 14 additional thoracic pathologies from standard AP and PA projections.
97.3% SensitivityVolumetric analysis of CT studies including pulmonary nodule detection, intracranial hemorrhage flagging, and abdominal organ segmentation.
94.8% SensitivityDeep learning models trained on 2.4 million annotated MRI slices for detection of white matter lesions, tumor margins, and spinal pathologies.
93.6% SensitivityWhole-slide image analysis for histopathology, supporting oncology teams with automated cell counting, tissue classification, and margin assessment.
96.1% SensitivityValidated against board-certified radiologist reads across 12 academic medical centers.
A transparent record of regulatory milestones and scientific peer review.
Received FDA 510(k) clearance for chest X-ray triage and CT pulmonary nodule detection. Two additional indications under active review.
Six studies published in Radiology, NEJM AI, and Nature Medicine documenting performance benchmarks across diverse patient populations.
Clinical deployment agreements signed with eight major health systems across the United States and European Union, covering 42 hospital sites.
CE Mark certification achieved under MDR 2017/745 for distribution in EU member states, expanding clinical availability across international markets.
Deployed across academic medical centers, community hospitals, and teleradiology networks.
Schedule a demo with our clinical team and review the full validation data for your imaging environment.